Subscribe
type here...
Subscribe

Tag: Petrovax

Petrovax began supplying quadrivalent influenza vaccine to the Russian market and abroad

News Pharma -
The total supply of the vaccine for Russian and foreign markets in 2022 will amount to more than 2.5 million doses

Petrovax pharmaceutical company received a patent for Longidase® in South Korea

Global Markets Pharma -
Petrovax has received a patent for the original medicine product Longidaza®, which is valid in South Korea protecting. During the...

Russia’s Petrovax ready to produce inhalable version of the Convidecia coronavirus vaccine

Manufacturing Pharma -
The launch of the project for the production of the inhalable version of the vaccine will depend on the...

Russian drug Longidaza® to help cope with post-Covid is patented in India

Manufacturing Pharma -
Longidaza®, developed in Russia, received a patent in India. This was reported by the company "Petrovax". Thus, Longidasa, which...

Petrovax presents its products in Europe

Manufacturing Pharma -
Russian pharmaceutical company Petrovax is expanding its export portfolio and considering new markets for its pharmaceuticals and vaccines. At...

Russian original medicine product Longidaza® has been patented in Europe

Manufacturing Pharma -
Petrovax Pharm LLC has received a European patent for the original medicine product Longidaza®, which is valid in the...

IDTM International Journal publishes first data on the use of Polyoxidonium as preventive medicine against COVID-19

Manufacturing Pharma -
The experience of using the Russian original medication Polyoxidonium (azoximer bromide) for preventive purposes among the personnel of the...

Petrovax to manufacture up to 10 mln doses of China’s Convidencia a month

Manufacturing Pharma -
The company said earlier that it planned to commission its Convidencia full cycle production line by the end of 2021.

Russian medicine to be supplied to Slovakia under special approval for the prevention of COVID-19

Manufacturing Pharma -
Polyoxidonium® (INN: Azoximer bromide) is an original Russian medication, which has been widely used in Russian clinical practice and exported to foreign countries for over 20 years.

Petrovax and Government of the Moscow Region Sign a Cooperation Agreement to Improve Economy of the Region

Manufacturing Pharma -
On June 3 during the St. Petersburg International Economic Forum 2021, Government of the Moscow region and NPO Petrovax...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026